ABSTRACT
Introduction Health-related quality of life (HRQoL) is an important HIV outcome beyond viral suppression. However, there are limited data characterizing HRQoL of key populations including female sex workers (FSW) living with HIV.
Methods We used baseline data (June 22, 2018-March 23, 2020) of FSW who were diagnosed with HIV and enrolled into a randomized trial in Durban, South Africa. HRQoL information was collected by a generic preference-accompanied tool with five domains (EQ-5D), and summarized into a single score (range 0-1) which represents health utility. We employed multivariable beta regression models to identify determinants of HRQoL and to estimate subgroup-specific HRQoL score. Using external estimates of life expectancy and population size, we estimated the number of quality adjusted life years reduced among FSW living with HIV in South Africa associated with violence and drug use.
Results Of 1363 individuals (mean age: 32.4 years; mean HRQoL score: 0.857) in our analysis, 62.6% used drugs, 61.3% experienced physical or sexual violence, and 64.6% self-reported taking antiretroviral treatment (ART). The following were associated with a reduction in the average marginal HRQoL score: older age (per decade: 0.018 [95% confidence interval (CI): 0.008, 0.027]), drug use (0.022 [0.007, 0.036]), experience of violence (0.024 [0.010, 0.038]), and moderate (vs. no) level of internalized stigma (0.023 [0.004, 0.041]). Current ART use was associated with a 0.015-point (−0.001, 0.031) increase in the HRQoL score. The estimated mean (95%CI) HRQoL scores ranged from 0.838 (0.816, 0.860) for FSW who used drugs, experienced violence, and were not on ART; to 0.899 (0.883, 0.916) for FSW who did not use drugs nor experience violence and were on ART. Our results can be translated into a reduction in 37,184 and 39,722 quality adjusted life years related to drug use and experience of violence, respectively in South Africa.
Conclusions These results demonstrate the association of ART with higher HRQoL among FSW and the need to further address structural risks including drug use, violence, and stigma. Population-specific estimates of HRQoL score can be further used to calculate quality-adjusted life years in economic evaluations of individual and structural interventions addressing the needs of FSW living with HIV.
Clinical Trial Registration NCT03500172 (April 17, 2018)
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Institutes of Health (R01NR016650).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the University of the Western Cape Biomedical Research Ethics Committee in South Africa; the Johns Hopkins School of Public Health Institutional Review Board in the United States, and the eThekwini Municipality and KwaZulu-Natal Provincial Departments of Health.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail addresses of authors: LW: Linwei.Wang{at}unityhealth.to
DWD: ddowdy1{at}jhmi.edu
CAC: ccomins1{at}jhu.edu
KY: katherine{at}tbhivcare.org
MM: Mfezi{at}tbhivcare.org
NM: Ntambue{at}tbhivcare.org
HM: Hlengiwe{at}tbhivcare.org
CC: cchen252{at}jhu.edu
HH: Hhausler{at}tbhivcare.org
SRS: sschwartz{at}jhu.edu
SB: sbaral{at}jhu.edu
SM: sharmistha.mishra{at}utoronto.ca
Data Availability
The data that support the findings of this study are available from the author, SB, upon reasonable request and approval.
List of Abbreviations
- HRQoL
- health-related quality of life
- PLHIV
- people living with HIV
- FSW
- female sex workers (FSW)
- ART
- antiretroviral treatment
- QALY
- quality adjusted life years
- CI
- confidence interval
- VAS
- visual analogue scale
- EQ-5D-3L
- EuroQoL five dimension, three level